CLA Intrinsic Valuation and Fundamental Analysis - Akari Therapeutics PLC

	Akari Therapeutics PLC F:CLA	US
1	11 Bit Studios SA XMUN:11C	PL
	DiaMedica Therapeutics Inc NASDAQ:DMAC	US

Intrinsic Value

The intrinsic value for Akari Therapeutics PLC (CLA) under the Base Case is 0.0325 EUR. Compared with the current market price of 0.0556 EUR, the stock appears Overvalued by 42% .

Intrinsic value calculated using DCF

€0.0325

Other reference points

Wall St target

€0.2399

Do our valuations actually work? See backtest results .

CLA Intrinsic Value

Overvaluation 42%

Intrinsic Value

Price €0.0556

Track Buy Zone

20% below Intrinsic Value €0.03

Get notified when the price drops into your buy zone

Current Price €0.06

Intrinsic Value €0.03

Margin of Safety 20% €0.03

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Akari Therapeutics PLC.

Explain Valuation